Standout Papers

Efficacy of a Tyrosine Kinase Inhibitor in Idiopathic Pulmonary Fibrosis 2011 2026 2016 2021 775
  1. Efficacy of a Tyrosine Kinase Inhibitor in Idiopathic Pulmonary Fibrosis (2011)
    Luca Richeldi, Ulrich Costabel et al. New England Journal of Medicine

Immediate Impact

7 from Science/Nature 74 standout
Sub-graph 1 of 17

Citing Papers

Nerandomilast in Patients with Idiopathic Pulmonary Fibrosis
2025 Standout
Alveolar fibroblast lineage orchestrates lung inflammation and fibrosis
2024 StandoutNature
6 intermediate papers

Works of Matthias Klüglich being referenced

Safety and pharmacokinetics of nintedanib and pirfenidone in idiopathic pulmonary fibrosis
2014
Efficacy of a Tyrosine Kinase Inhibitor in Idiopathic Pulmonary Fibrosis
2011 Standout

Author Peers

Author Last Decade Papers Cites
Matthias Klüglich 65 27 864 321 155 7 1.0k
Michèle Brun 34 1 759 287 125 5 893
Yolanda Mageto 20 1 845 271 94 9 1.1k
Bridget McGarry 38 6 679 200 87 15 1.1k
Brent W. Kinder 20 755 358 123 16 992
Louis J. Vuga 30 4 883 219 97 14 1.2k
Antje Moeller 38 1 1003 140 64 5 1.2k
R.M. duBois 29 8 937 281 99 15 1.3k
Roland du Bois 44 2 977 704 128 18 1.2k
Kazuhisa Konishi 59 3 1030 203 69 13 1.3k
Rochelle L. Argentieri 26 7 626 257 70 13 1.2k

All Works

Loading papers...

Rankless by CCL
2026